STAGE IV ESOPHAGEAL CANCER AJCC V7
Clinical trials for STAGE IV ESOPHAGEAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV ESOPHAGEAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV ESOPHAGEAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for tough esophageal cancer
Disease control OngoingThis study tests whether adding the drug cixutumumab to standard chemotherapy (paclitaxel) can help people with advanced esophageal or stomach-junction cancer live longer without their cancer growing. About 94 adults whose cancer has spread and who have already tried one treatmen…
Matched conditions: STAGE IV ESOPHAGEAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
Experimental pill aims to boost radiation against tough gut cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The goal is to find the safest dose and see if it makes tumor cells more sensitive to radiation therapy. Nineteen participants with cancer…
Matched conditions: STAGE IV ESOPHAGEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC